EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation

Xiao Jiang, Lan Li, Tao Wei, Yu Deng, Li Chang, Wenhui Li

Electronic Journal of Biotechnology · 2026-11 · 84 · 100735

DOI: 10.1016/j.ejbt.2026.100735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Electronic Journal of Biotechnology, 2026-11. Verfasst von Xiao Jiang und 5 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yunnan Provincial Department of Education Science Research Fund Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Yunnan Provincial Department of Education Science Research Fund Project

Zitieren

APA

Jiang, X., Li, L., Wei, T., Deng, Y., Chang, L., & Li, W. (2026). Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation. Electronic Journal of Biotechnology, 84, 100735. https://doi.org/10.1016/j.ejbt.2026.100735

Vancouver

Jiang X, Li L, Wei T, Deng Y, Chang L, Li W. Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation. Electronic Journal of Biotechnology. 2026;84:100735. doi:10.1016/j.ejbt.2026.100735

BibTeX
@article{Jiang2026,
  author = {Jiang, Xiao and Li, Lan and Wei, Tao and Deng, Yu and Chang, Li and Li, Wenhui},
  title = {Taxifolin as a novel antimetastatic agent for lung adenocarcinoma: A network pharmacology and experimental validation},
  journal = {Electronic Journal of Biotechnology},
  year = {2026},
  volume = {84},
  pages = {100735},
  doi = {10.1016/j.ejbt.2026.100735}
}
Kostenlos starten →